Search Results - "Wygant, Gail"

Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses by Weycker, Derek, Wygant, Gail DeVecchis, Guo, Jennifer D., Lee, Theodore, Luo, Xuemei, Rosenblatt, Lisa, Mardekian, Jack, Atwood, Mark, Hanau, Ahuva, Cohen, Alexander T.

“…In the phase 3 trial Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy, apixaban was noninferior to…”
Get full text

Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation by Martin, Amber L, Reeves, Alessandra G, Berger, Samantha E, Fusco, Manuela Di, Wygant, Gail D, Savone, Mirko, Snook, Kassandra, Nejati, Mina, Lanitis, Tereza

“…Economic consequences associated with the rise in nonvitamin K antagonist oral anticoagulant use on a societal level remain unclear. Evidence from the past…”
Get full text

Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in China by Chen, Wen, Ward, Thomas, Tan, Mai Ping, Yan, Jing, Wang, Peter Feng, Wygant, Gail D, Gordon, Jason

“…To evaluate the cost–effectiveness of the novel all-oral direct-acting antiviral regimen daclatasvir + asunaprevir (DUAL), versus interferon-based regimens for…”
Get full text

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US by Stephenson, Judith J., Chang, Chun-Lan, DeVecchis Wygant, Gail, Hauch, Ole, Cziraky, Mark J.

“…Abstract Background/objective: Guidelines support clopidogrel therapy in medically-treated or percutaneous coronary intervention (PCI) patients after…”
Get full text

A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation by Samsa, Greg, Matchar, David B, Dolor, Rowena J, Wiklund, Ingela, Hedner, Ewa, Wygant, Gail, Hauch, Ole, Marple, Cheryl Beadle, Edwards, Roger

“…Anticoagulation can reduce quality of life, and different models of anticoagulation management might have different impacts on satisfaction with this component…”
Get full text

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice by Weycker, Derek, Li, Xiaoyan, Wygant, Gail DeVecchis, Lee, Theodore, Hamilton, Melissa, Luo, Xuemei, Vo, Lien, Mardekian, Jack, Pan, Xianying, Burns, Leah, Atwood, Mark, Hanau, Ahuva, Cohen, Alexander T

“…In the AMPLIFY clinical trial, apixaban was non-inferior to warfarin plus subcutaneous enoxaparin bridge therapy in the treatment of acute venous…”
Get more information

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database by Menzin, Joseph, Wygant, Gail, Hauch, Ole, Jackel, Juliana, Friedman, Mark

“…ABSTRACT Objective: Acute coronary syndromes (ACS) are life-threatening disorders requiring intensive medical management or invasive cardiovascular procedures…”
Get full text

Abstract 15444: Anticoagulation Treatment of Venous Thromboembolism Across the Weight Spectrum: Insights From the Veterans Health Administration by Perino, Alexander C, Fan, Jun, Kothari, Mitra, MOHAMMAD, ATIF, Hlavacek, Patrick, Wygant, Gail D, Schmitt, Susan K, Pundi, Krishna, Heidenreich, Paul A, Guo, Jennifer, Turakhia, Mintu

“…IntroductionIn seminal trials of venous thromboembolism (VTE) treatment with direct oral anticoagulants (DOAC), few patients were enrolled at low and high body…”
Get full text

Effectiveness and Safety of Apixaban Vs Warfarin Among Venous Thromboembolism Patients Using Five US Databases: A Subgroup Analysis of Obesity by Cohen, Alexander T, Sah, Janvi, Lee, Theodore, Wygant, Gail, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Delinger, Rachel, Luo, Xuemei

“…Background: Obesity is associated with an increased risk of VTE. Although four direct oral anticoagulants (DOACs) have been approved for the treatment of VTE,…”
Get full text

Major Bleeding and Bleeding Events Requiring Hospitalization in the First Three Months Following Vitamin K Antagonists Therapy in Patients with First Venous Thromboembolism by Martinez, Carlos, Cohen, Alexander, Katholing, Anja, Wallenhorst, Christopher, Li, Xiaoyan, Wygant, Gail

“…Introduction: The management of venous thromboembolism (VTE) and the prevention of recurrent VTE consists of anticoagulation primarily with Vitamin K…”
Get full text

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale by Cohen, Alexander T, Keshishian, Allison, Lee, Theodore, Wygant, Gail, Rosenblatt, Lisa, Hlavacek, Patrick, Mardekian, Jack, Wiederkehr, Daniel, Sah, Janvi, Luo, Xuemei

“…▪ BACKGROUND: Cancer is an independent risk factor for venous thromboembolism (VTE) and the strongest predictor for all-cause and pulmonary embolism-related…”
Get full text

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases by Cohen, Alexander T, Keshishian, Allison, Lee, Theodore, Wygant, Gail, Rosenblatt, Lisa, Hlavacek, Patrick, Mardekian, Jack, Wiederkehr, Daniel, Sah, Janvi, Luo, Xuemei

“…▪ BACKGROUND: Venous thromboembolism (VTE) is the second leading cause of death in cancer patients. The treatment of cancer-associated VTE carries a…”
Get full text

Abstract 3367: Treatment patterns in patients with cancer-associated venous thromboembolism in the US: A real world retrospective database analysis by Guo, Jennifer D., Hlavacek, Patrick, Poretta, Tayla, Wygant, Gail, Lane, Daniel C., Gorritz, Magdaliz, Wang, Xin, Chen, Chi-Chang, Pan, Xianying, Rosenblatt, Lisa

“…Abstract Background: Cancer patients have higher risk of venous thromboembolism (VTE) due to the cancer-induced hypercoagulable state or activation of the…”
Get full text

COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT ACTIVE CANCER by Wygant, Gail D., Guo, Jennifer, Rosenblatt, Lisa, Weycker, Derek, Li, Shawn, Lee, Theodore, Luo, Xuemei, Mardekian, Jack, Hanau, Ahuva, Atwood, Mark, Pan, Xianying, Cohen, Alexander (Ander)

Get full text

Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA by Oguz, Mustafa, Lanitis, Tereza, Li, Xiaoyan, Wygant, Gail, Singer, Daniel E., Friend, Keith, Hlavacek, Patrick, Nikolaou, Andreas, Mattke, Soeren

“…Background There is limited evidence on the clinical and cost benefits of screening for atrial fibrillation (AF) with electrocardiogram (ECG) in asymptomatic…”
Get full text

SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM by Weycker, Derek, Li, Xiaoyan, Wygant, Gail, Lee, Theodore, Hamilton, Melissa, Luo, Xuemei, Vo, Lien, Mardekian, Jack, Pan, Xianying, Burns, Leah, Atwood, Mark

Get full text

COST-EFFECTIVENESS OF EXTENDED AND ONE-TIME SCREENING FOR ATRIAL FIBRILLATION VERSUS NO SCREENING IN THE UNITED STATES by Wygant, Gail D., Oguz, Mustafa, Lanitis, Tereza, Leipold, Robert, Friend, Keith, Mattke, Soeren, Singer, Daniel, Nikolaou, Andreas, Hlavacek, Patrick, Li, Shawn

Get full text

REAL-WORLD EVALUATION OF HOSPITAL LENGTH OF STAY AND COST FOR APIXABAN VERSUS WARFARIN TREATMENT OF HOSPITALIZED VENOUS THROMBOEMBOLISM PATIENTS IN THE US by Lin, Jay, Vo, Lien, Wygant, Gail, Hlavacek, Patrick, Rosenblatt, Lisa, Gupta, Anu, Pan, Xianying, Mardekian, Jack, Lingohr-Smith, Melissa, Menges, Brandy, Tuell, Kenneth, Guo, Jennifer

“…Multivariable generalized linear models were carried out to compare hospital LOS and cost, while controlling for key differences in patient and hospital…”
Get full text

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis by Reynolds, Matthew W, Fahrbach, Kyle, Hauch, Ole, Wygant, Gail, Estok, Rhonda, Cella, Catherine, Nalysnyk, Luba

“…To examine the relationship between international normalized ratio (INR) and outcomes (major bleeding events and strokes) in patients with atrial fibrillation…”
Get more information

Abstract 263: Real World Outpatient Treatment Patterns of Patients with Cancer-Associated Venous Thromboembolism in the US by Guo, Jennifer D, Hlavacek, Patrick, Poretta, Tayla, Wygant, Gail, Lane, Daniel C, Gorritz, Magdaliz, Wang, Xin, Chen, Chi-Chang, Pan, Xianying, Rajpura, Jigar, Stwalley, Brian, Rosenblatt, Lisa

“…Abstract only Objective: The aim of the study is to describe post-discharge treatment patterns in patients with cancer-associated venous thromboembolism (VTE)…”
Get full text